Breast Cancer Drug Kisqali Increases Survival Rates 30% A new drug drastically improves survival rates of younger women with the most common type of breast cancer. Presented at the annual meeting of the American Society of Clinical Oncology in Chicago researchers showed that the addition of cell-cycle inhibitor ribociclib increased survival rates to 70 percent Read more